Identification of a synthetic cannabinoid A-836339 as a novel compound found in a product

被引：11

作者：

Uemura, Nozomi ^{[1
]}

Fukaya, Haruhiko ^{[2
]}

Kanai, Chieko ^{[1
]}

Yoshida, Masao ^{[1
]}

Nakajima, Jun'ichi ^{[1
]}

Takahashi, Misako ^{[1
]}

Suzuki, Jin ^{[1
]}

Moriyasu, Takako ^{[1
]}

Nakae, Dai ^{[1
]}

机构：

[1] Tokyo Metropolitan Inst Publ Hlth, Shinjuku Ku, Tokyo 1690073, Japan

[2] Tokyo Univ Pharm & Life Sci, Instrumental Anal Ctr, Hachioji, Tokyo 19203, Japan

来源：

FORENSIC TOXICOLOGY | 2014年 / 32卷 / 01期

关键词：

A-836339; Synthetic cannabinoid; X-Ray crystallographic analysis; TOF-MS; NMR; DESIGNER DRUGS; DERIVATIVES; FUBINACA; AGONIST; ANALOG; ACID;

D O I：

10.1007/s11419-013-0201-x

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

As a part of the work conducted in our laboratory, we encountered a case in which new chemical compound was contained in a certain product. This compound was found to have a molecular weight of 310 Da by liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry. Accurate mass spectrometry measurements showed that the compound had an elemental composition of C16H26N2O2S. Using these mass data together with those obtained by nuclear magnetic resonance analysis and X-ray crystallographic analysis, this compound was identified as N-[3-(2-methoxyethyl)-4,5-dimethyl-2(3H)-thiazolylidene]-2,2,3,3-tetramethylcyclopropanecarboxamide, which was reported in 2009 and named A-836339. It was described as a thiazol derivative and a selective agonist of G-protein-coupled cannabinoid receptor CB2. This is the first report to identify this compound in a dubious product.

引用

页码：45 / 50

页数：6

共 21 条

[11]

Sheldrick G.M., 2008, SADABS BRUK AXS AR D

[12]

Sheldrick G. M., 1997, SHELXL-97, Programs for Crystal Structure Analysis

[13] Identification and analytical properties of new synthetic cannabimimetics bearing 2,2,3,3-tetramethylcyclopropanecarbonyl moiety [J].

Shevyrin, Vadim ;

Melkozerov, Vladimir ;

Nevero, Alexander ;

Eltsov, Oleg ;

Morzherin, Yuri ;

Shafran, Yuri .

FORENSIC SCIENCE INTERNATIONAL, 2013, 226 (1-3) :62-73

[14] Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products [J].

Uchiyama, Nahoko ;

Matsuda, Satoru ;

Kawamura, Maiko ;

Kikura-Hanajiri, Ruri ;

Goda, Yukihiro .

FORENSIC TOXICOLOGY, 2013, 31 (02) :223-240

[15] URB-754: A new class of designer drug and 12 synthetic cannabinoids detected in illegal products [J].

Uchiyama, Nahoko ;

Kawamura, Maiko ;

Kikura-Hanajiri, Ruri ;

Goda, Yukihiro .

FORENSIC SCIENCE INTERNATIONAL, 2013, 227 (1-3) :21-32

[16] New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products [J].

Uchiyama, Nahoko ;

Matsuda, Satoru ;

Wakana, Daigo ;

Kikura-Hanajiri, Ruri ;

Goda, Yukihiro .

FORENSIC TOXICOLOGY, 2013, 31 (01) :93-100

[17] Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in illegal products [J].

Uchiyama, Nahoko ;

Kawamura, Maiko ;

Kikura-Hanajiri, Ruri ;

Goda, Yukihiro .

FORENSIC TOXICOLOGY, 2012, 30 (02) :114-125

[18] Identification of a cannabimimetic indole as a designer drug in a herbal product [J].

Uchiyama, Nahoko ;

Kikura-Hanajiri, Ruri ;

Kawahara, Nobuo ;

Goda, Yukihiro .

FORENSIC TOXICOLOGY, 2009, 27 (02) :61-66

[19] Identification of a Cannabinoid Analog as a New Type of Designer Drug in a Herbal Product [J].

Uchiyama, Nahoko ;

Kikura-Hanajiri, Ruri ;

Kawahara, Nobuo ;

Haishima, Yuji ;

Goda, Yukihiro .

CHEMICAL & PHARMACEUTICAL BULLETIN, 2009, 57 (04) :439-441

[20] Characterization of a Cannabinoid CB2 Receptor-Selective Agonist, A-836339 [2,2,3,3-Tetramethyl-cyclopropanecarboxylic Acid [3-(2-Methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], Using in Vitro Pharmacological Assays, in Vivo Pain Models, and Pharmacological Magnetic Resonance Imaging [J].

Yao, Betty B. ;

Hsieh, Gin ;

Daza, Anthony V. ;

Fan, Yihong ;

Grayson, George K. ;

Garrison, Tiffany Runyan ;

El Kouhen, Odile ;

Hooker, Bradley A. ;

Pai, Madhavi ;

Wensink, Erica J. ;

Salyers, Anita K. ;

Chandran, Prasant ;

Zhu, Chang Z. ;

Zhong, Chengmin ;

Ryther, Keith ;

Gallagher, Megan E. ;

Chin, Chih-Liang ;

Tovcimak, Ann E. ;

Hradil, Vincent P. ;

Fox, Gerard B. ;

Dart, Michael J. ;

Honore, Prisca ;

Meyer, Michael D. .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (01) :141-151

← 1 2 3 →